Início › Doenças Autoimunes › Texas › Houston
Ensaios clínicos de Doenças Autoimunes em Houston, TX
21 estudos para Doenças Autoimunes estão buscando participantes em locais em Houston e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
RecrutandoFase 2
- MD Anderson Cancer Center, Houston
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecrutandoFase 3
- Abigail Neiman MD PA, Houston
- Novel Research LLC, Bellaire · a 7 mi de distância
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecrutandoFase 2
- Jade Clinical Site, Houston
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecrutandoFase 1
- UT MD Anderson Cancer Center, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecrutandoFase 3
- Baylor College of Medicine, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecrutandoFase 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
RecrutandoFase 2
- University of Texas - Houston, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecrutandoFase 3
- Baylor College of Medicine, Houston
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecrutandoFase 3
- GSK Investigational Site, Houston
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
RecrutandoFase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecrutandoFase 3
- Nephro Asso North Illinois Indiana, Houston
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecrutandoFase 1/2
- Baylor College of Medicine Neurology Department, Houston
- Houston Methodist Hospital, Houston
- University of Texas MD Anderson Cancer Center, Houston
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RecrutandoFase 3
- Texas Children's Hospital/ Baylor College of Medicine, Houston
Study of BHV-1300 in Graves' Disease
RecrutandoFase 1
- Site-106, Houston
- Site-101, Houston
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
RecrutandoFase 3
- Site Number - 1057, Houston
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
RecrutandoFase 2/3
- Houston Methodist Hospital, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
RecrutandoFase 1/2
- MD Anderson Texas Medical Center, Houston
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RecrutandoEstudo observacional
- M D Anderson Cancer Center, Houston
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
RecrutandoFase 1/2
- MD Anderson Cancer Center, Houston
- The University of Texas Health Science Center at Houston, Houston
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
RecrutandoFase 1
- Houston Methodist Hospital, Houston
Ensaios de Doenças Autoimunes em outras cidades
- Washington, DC19 estudos
- New York City, NY19 estudos
- Philadelphia, PA16 estudos
- Durham, NC15 estudos
- Boston, MA13 estudos
- Los Angeles, CA12 estudos
- Chicago, IL12 estudos
- Dallas, TX9 estudos
- Cleveland, OH8 estudos
- Milwaukee, WI8 estudos
- Atlanta, GA8 estudos
- Portland, OR8 estudos
Outros estudos em Houston
- Câncer de Pulmão de Não Pequenas Células145 estudos
- Câncer de Mama126 estudos
- Câncer (todos os tipos)121 estudos
- Câncer Metastático104 estudos
- Câncer Colorretal102 estudos
- Câncer de Ovário89 estudos
- Leucemia Mieloide Aguda85 estudos
- Câncer de Pulmão78 estudos
- Câncer de Próstata76 estudos
- Câncer Endometrial68 estudos
- Câncer de Pâncreas61 estudos
- Melanoma59 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.